Romosozumab/Denosumab Study for Premenopausal IOP
Romosozumab/Denosumab Study for Premenopausal IOP
Active, not recruiting · NCT04800367 · Registry updated 2026-02-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Romosozumab/Denosumab Study for Premenopausal IOP | Premenopausal Idiopathic Osteoporosis | Active, not recruiting | Phase 2 | 2026-02-27 | NCT04800367 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amgen | 180 |
| Columbia University | 375 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University Irving Medical Center | New York | United States | 234 |